Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Utilization for protein synthesis in individual rat organs of extracellular 2-ketoisocaproate relative to utilization of extracellular leucine

Journal Article · · Metab., Clin. Exp.; (United States)
Rats were given constant intravenous infusions of (/sup 3/H)-leucine plus (1-/sup 14/C)-2-ketoisocaproate (KIC). Specific activities of plasma leucine and plasma KIC reached plateaus by two to three hours. /sup 3/H specific activity of KIC was 85% +/- 2% of that in leucine. /sup 14/C specific activity of leucine was 36% +/- 2% of that in KIC. The /sup 14/C//sup 3/H ratios in leucine and KIC were constant from the earliest sampling time (one hour) at 0.65 +/- 0.03 and 2.20 +/- 0.07, respectively. In various tissues, /sup 14/C//sup 3/H in free leucine and in tissue protein were approximately equal, but in most organs these ratios were significantly greater than the ratio /sup 14/C//sup 3/H in plasma leucine. From these data we estimate that the fraction of leucine incorporated into protein in individual organs derived from extracellular KIC rather than extracellular leucine varies from zero (in liver and bone marrow) to 35% to 45% (in brain and heart), and comprises 12% in the body as a whole.
Research Organization:
Johns Hopkins Univ. School of Medicine, Baltimore, MD (USA)
OSTI ID:
5821606
Journal Information:
Metab., Clin. Exp.; (United States), Journal Name: Metab., Clin. Exp.; (United States) Vol. 38:7; ISSN METAA
Country of Publication:
United States
Language:
English